Jasper Therapeutics JSPR Stock
Jasper Therapeutics Price Chart
Jasper Therapeutics JSPR Financial and Trading Overview
| Jasper Therapeutics stock price | 0.7 USD |
| Previous Close | 0.7 USD |
| Open | 0.71 USD |
| Bid | 0.49 USD x 200 |
| Ask | 0.86 USD x 200 |
| Day's Range | 0.66 - 0.71 USD |
| 52 Week Range | 0.32 - 2.87 USD |
| Volume | 251.89K USD |
| Avg. Volume | 1.53M USD |
| Market Cap | 22.93M USD |
| Beta (5Y Monthly) | 3.029 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.93 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.38 USD |
JSPR Valuation Measures
| Enterprise Value | 16.22M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.2691797 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 5.6950417 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.31 |
Trading Information
Jasper Therapeutics Stock Price History
| Beta (5Y Monthly) | 3.029 |
| 52-Week Change | -75.035% |
| S&P500 52-Week Change | 19.66% |
| 52 Week High | 2.87 USD |
| 52 Week Low | 0.32 USD |
| 50-Day Moving Average | 0.64 USD |
| 200-Day Moving Average | 1.11 USD |
JSPR Share Statistics
| Avg. Volume (3 month) | 1.53M USD |
| Avg. Daily Volume (10-Days) | 790.27K USD |
| Shares Outstanding | 33.27M |
| Float | 30.01M |
| Short Ratio | 1.93 |
| % Held by Insiders | 2.55% |
| % Held by Institutions | 39.50% |
| Shares Short | 5.36M |
| Short % of Float | 16.40% |
| Short % of Shares Outstanding | 16.10% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -113.40% |
| Return on Equity (ttm) | -255.045% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -52303000 USD |
| Net Income Avi to Common (ttm) | -31771000 USD |
| Diluted EPS (ttm) | -0.93 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 7.31M USD |
| Total Cash Per Share (mrq) | 0.22 USD |
| Total Debt (mrq) | 270K USD |
| Total Debt/Equity (mrq) | 19.11 USD |
| Current Ratio (mrq) | 1.475 |
| Book Value Per Share (mrq) | 0.121 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -60333000 USD |
| Levered Free Cash Flow (ttm) | -39979000 USD |
Profile of Jasper Therapeutics
| Country | United States |
| State | CA |
| City | Redwood City |
| Address | 2200 Bridge Pkwy |
| ZIP | 94065 |
| Phone | 650 549 1400 |
| Website | https://jaspertx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 22 |
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast stem cell driven diseases in the United States. The company's lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factors from binding to and signaling through the CD117 receptor on mast and stem cells. It focuses on the development and commercialization of therapeutic agents for patients with various mast cell driven diseases, including chronic spontaneous urticaria, chronic inducible urticaria, and asthma. Jasper Therapeutics, Inc. was founded in 2018 and is headquartered in Redwood City, California.
Q&A For Jasper Therapeutics Stock
What is a current JSPR stock price?
Jasper Therapeutics JSPR stock price today per share is 0.7 USD.
How to purchase Jasper Therapeutics stock?
You can buy JSPR shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Jasper Therapeutics?
The stock symbol or ticker of Jasper Therapeutics is JSPR.
Which industry does the Jasper Therapeutics company belong to?
The Jasper Therapeutics industry is Biotechnology.
How many shares does Jasper Therapeutics have in circulation?
The max supply of Jasper Therapeutics shares is 33.27M.
What is Jasper Therapeutics Price to Earnings Ratio (PE Ratio)?
Jasper Therapeutics PE Ratio is now.
What was Jasper Therapeutics earnings per share over the trailing 12 months (TTM)?
Jasper Therapeutics EPS is -0.93 USD over the trailing 12 months.
Which sector does the Jasper Therapeutics company belong to?
The Jasper Therapeutics sector is Healthcare.
Jasper Therapeutics JSPR included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26402.42 USD — |
-0.52
|
7.53B USD — | 26359.27 USD — | 26700.68 USD — | — - | 7.53B USD — |
|
US Tech Health Care
IXHC
US
|
1339.84 USD — |
-2.05
|
— — | 1338.76 USD — | 1360.4 USD — | — - | — — |
- {{ link.label }} {{link}}
